- Home
- Publications
- Publication Search
- Publication Details
Title
The role of miR-223 in breast cancer; an integrated analysis
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1007/s11033-023-08850-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology
- (2022) Kelly A. Hirko et al. BMC Medicine
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-203 suppresses pancreatic cancer cell proliferation and migration by modulating DUSP5 expression
- (2022) Zekiye Altan et al. MOLECULAR AND CELLULAR PROBES
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The regulatory role of antisense lncRNAs in cancer
- (2021) Biao Liu et al. Cancer Cell International
- Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
- (2020) Dong Li et al. OncoTargets and Therapy
- Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
- (2020) Peng Lv et al. BIOSCIENCE REPORTS
- Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation
- (2020) Hongbo Qu et al. Frontiers in Oncology
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis
- (2019) Bing Yao et al. FEBS Open Bio
- Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer
- (2019) Francesca Citron et al. CANCER RESEARCH
- Clustered miRNAs and their role in biological functions and diseases
- (2018) Shama P. Kabekkodu et al. BIOLOGICAL REVIEWS
- MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer
- (2018) Yanfang Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6
- (2018) Quanbo Ji et al. MOLECULAR THERAPY
- EGR1-mediated transcription of lncRNA-HNF1A-AS1 promotes cell cycle progression in gastric cancer
- (2018) Hai-Ting Liu et al. CANCER RESEARCH
- An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
- (2018) Kioomars Saliminejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement
- (2017) Reeta Kangas et al. Oncotarget
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
- (2016) Kristina Magnusson et al. BMC CANCER
- MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
- (2016) Caterina Catalanotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1
- (2016) Xu Sun et al. PLoS One
- Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas
- (2016) Jeremy T-H. Chang et al. PLoS One
- Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs
- (2014) Fabiola Olivieri et al. AGING CELL
- The role of miRNAs in cancer: from pathogenesis to therapeutic implications
- (2014) Mehmet Seven et al. Future Oncology
- Rôle des longs ARN non codants dans le développement normal et pathologique
- (2014) Ève-Lyne Mathieu et al. M S-MEDECINE SCIENCES
- microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1
- (2013) M. M. Streppel et al. CLINICAL CANCER RESEARCH
- Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
- (2013) S Masciarelli et al. ONCOGENE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
- (2011) X. Li et al. MOLECULAR CANCER RESEARCH
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
- (2011) Cheng You Jia et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search